Announced details
Promotion of women's participation and advancement, long-term corporate value enhancement, talent utilization, and support for balancing treatment and employment
Women account for more than 50% of employees, approximately 40% of project leaders are women, the gender pay gap has been almost eliminated, and all employees diagnosed with cancer have returned to work
Second selection, following FY2021
Shin Nippon Biomedical Laboratories was selected under the brand selection program jointly organized by the Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange.
The Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange. Other information, including their locations, representatives, capital and year of establishment, is Not disclosed
FY2025 Nadeshiko Brand
Ministry of Economy, Trade and Industry, Tokyo Stock Exchange
Kagoshima City, Kagoshima Prefecture
The program aims to promote investment in companies by introducing selected companies as attractive investment opportunities for investors who prioritize long-term corporate value enhancement. The impact on Shin Nippon Biomedical Laboratories' own financial performance is Not disclosed
The company does not address Contract Value / Offering price.
Ministry of Economy, Trade and Industry: Selection of listed companies with outstanding performance in promoting women's participation and advancement, “Nadeshiko Brand”
| Item | Details |
|---|---|
| Names of Products / Services Covered | FY2025 Nadeshiko Brand |
| Counterparty | Ministry of Economy, Trade and Industry, Tokyo Stock Exchange |
| Counterparty overview | The Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange. Other information, including their locations, representatives, capital and year of establishment, is Not disclosed |
| Relationship with the Company | Shin Nippon Biomedical Laboratories was selected under the brand selection program jointly organized by the Ministry of Economy, Trade and Industry and the Tokyo Stock Exchange. |
| Applicable area | Promotion of women's participation and advancement, long-term corporate value enhancement, talent utilization, and support for balancing treatment and employment |
| Award/certification name | FY2025 Nadeshiko Brand |
| Awarding / certifying body | Ministry of Economy, Trade and Industry, Tokyo Stock Exchange |
| Location | Kagoshima City, Kagoshima Prefecture |
| Quantitative Effects | Women account for more than 50% of employees, approximately 40% of project leaders are women, the gender pay gap has been almost eliminated, and all employees diagnosed with cancer have returned to work |
| Usage history | Second selection, following FY2021 |
| Impact on Business Performance | The program aims to promote investment in companies by introducing selected companies as attractive investment opportunities for investors who prioritize long-term corporate value enhancement. The impact on Shin Nippon Biomedical Laboratories' own financial performance is Not disclosed |
| Source | Ministry of Economy, Trade and Industry: Selection of listed companies with outstanding performance in promoting women's participation and advancement, “Nadeshiko Brand” |
Items this document does not state (6)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company was recognized for achievements including a strategy aligned with its characteristics as a company based in Kagoshima with global operations, more than 50 policy improvements centered on the Working Nadeshiko Committee, the appointment of women to decision-making positions, and initiatives and talent utilization that also take external evaluations into account.